The principle behind GynTect®, detection of specific epigenetic DNA methylation markers, is not restricted to cervical cancer diagnostics. Together with clinical partners oncgnostics works on the validation of markers and development of tests even for other cancers.

Our project pipeline currently focuses on applications in the two following fields :

    • ovarian cancer
    • head-and-neck tumors